Author name: Yali Friedman

From the laboratory to the investment fund How two Chilean scientists turned a graduate thesis into a business that is […]

Biotech: A Big Future Behind It? Despite a bumpy 2004, the rush to market hasn’t abated. The key for this

The State of Stem Cell Research Californians are hoping that stem cell research will do for them what the invention

The Human Genome, Take Two When a sequenced human genome was announced in 2001, most people missed a crucial part

Big Pharma’s Ails Could Spread To Biotech It is no secret big drugmakers are sick. Investors should worry that their

Big Pharma’s Ails Could Spread To Biotech It is no secret big drugmakers are sick. Investors should worry that their

Financial Snapshot For December Financial Snapshot For December 2004: Sideways

Facing Biotech Foods Without the Fear Factor “Almost everywhere food is sold these days, you are likely to find products

Big Changes for Big Pharma Fallout from Vioxx and Celebrex will create plenty of pain in the sector. Here are

Biotechs forced to work harder to fill openings: Bay Area biotech companies are scrambling to attract and retain both researchers